Kenya - English - Pharmacy and Poisons Board

north china pharmaceutical co., ltd. no. 388 heping east road, shijiazhuang, hebei, - co-amoxiclav for injection - powder for injection - 1.2 g - amoxicillin and enzyme inhibitor

Kenya - English - Pharmacy and Poisons Board

denk pharma gmbh & co kg prinzregentenstr 79 d-81675 munchen - amoxiclav trihydrate clavulanate potassium - powder for oral solution in sachet - strength: one sachet contains 1148 mg amoxicillin… - beta-lactamantibacterials: combinations of

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

austell pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains amoxycillin trihydrate equivalent to amoxycillin 250,0 mg potassium clavulanate equivalent to clavulanic acid 125,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

austell pharmaceuticals (pty) ltd - suspension - see ingredients - each 5,0 ml suspension contains amoxycillin trihydrate equivalent to amoxycillin 200,0 mg potassium clavulanate equivalent to clavulanic acid 28,5 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

austell pharmaceuticals (pty) ltd - suspension - see ingredients - each 5,0 ml suspension contains amoxycillin trihydrate equivalent to amoxycillin 400,0 mg potassium clavulanate equivalent to clavulanic acid 57,0 mg

Philippines - English - FDA (Food And Drug Administration)

maxipharm co. ltd - co-amoxiclav - film-coated tablet - 500mg/ 125mg

Philippines - English - FDA (Food And Drug Administration)

the cathay drug co., inc. - co-amoxiclav - sterile powder for injection i.v. - 1g/ 200mg

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dafra pharma gmbh - artemether 180mg, lumefantrine 1080mg - co-artesiane is indicated for the treatment of malaria in children, caused by all forms of plasmodium including severe malaria caused by multiple drug resistant strains of p. falciparum. in case of a p. vivax malaria infection an additional treatment with primaquine may be required.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

averroes pharmaceuticals sdn. bhd. - potassium clavulanate; amoxicillin sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - potassium clavulanate, quantity: 148.875 mg; amoxicillin trihydrate, quantity: 1006.25 mg - tablet, film coated - excipient ingredients: ethylcellulose; isopropyl alcohol; microcrystalline cellulose; purified talc; dichloromethane; magnesium stearate; propylene glycol; croscarmellose sodium; hypromellose; titanium dioxide; hyprolose; industrial methylated spirit - medreich co-amoxiclav 500/125 and medreich co-amoxiclav 875/125 tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology):,urinary tract infections (uncomplicated and complicated),lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis,upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis.,skin and skin structure infection,appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxicillin and clavulanic acid tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate.,the treatment of mixed infections caused by amoxicillin susceptible organisms and beta-lactamase producing organisms susceptible to amoxicillin and clavulanic acid tablets should not require the addition of another antibiotic due to the amoxicillin content of these products.